Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,644 public trials 847 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Active, Not Recruiting

Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma

NCT05263583

Conditions
Burkitt Lymphoma, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +24 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Henan Cancer Hospital Henan, China
  • Shanghai East Hospital Pudong, China
View Trial Details
Active, Not Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma

NCT05201248

Conditions
B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • The Fifth Medical Center of PLA General Hospital /ID# 230520 Beijing, Beijing Municipality, China
  • Peking University Third Hospital /ID# 228138 Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital /ID# 231890 Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer Center /ID# 228033 Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Active, Not Recruiting

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

NCT03386513

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Disease Attributes, +25 more
Locations
  • Banner Health MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Stanford, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)

NCT03385226

Conditions
Cutaneous T Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +16 more
Locations
  • University Hospital Birmingham Birmingham, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
  • University Hospital Coventry Coventry, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
View Trial Details
Active, Not Recruiting

RadiothErapy priMIng for CAR-T

NCT04726787

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • St James's University Hospital Leeds, United Kingdom
  • Kings College Hospital London, United Kingdom
  • Freeman Hospital Newcastle, United Kingdom
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma

NCT03671018

Conditions
B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 29 locations
View Trial Details

Related conditions